Koyfin Home > Directory > Health Care > Alder Biopharma > EV / EBITDA (ntm)

Alder Biopharma EV / EBITDA (ntm) Chart (ALDR)

Alder Biopharma annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Price / Book for the quarter ending March 03, 2018 was 3.09 a 34.98% increase of 1.08 year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin